![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
April 24, 2026
A preview of the upcoming Spring Group Meeting, a recap of AACR 2026, and an update on the current state of the NCI's cancer research efforts
April 24, 2026
The latest clinical trial findings in breast cancer, cancer control and survivorship, health equity, leukemia, melanoma, and NCI-MATCH
March 30, 2026
The co-chairs reflect on the rapidly evolving definition of sensitive research data and highlight priorities for building secure data environments that sustain patient protection and public trust
February 27, 2026
Progress in geriatric oncology, reflections on regulatory complexity, and an exciting new trial in small cell lung cancer
February 27, 2026
This phase 2 study is evaluating ivonescimab, a novel therapy designed to target the PD-1 and VEGF pathways simultaneously
February 27, 2026
The latest clinical trial findings in breast cancer, leukemia, lymphoma, lung cancer, NCI-MATCH, and prostate cancer
January 30, 2026
The co-chairs reflect on last year's key research advances and highlight priorities for 2026
December 19, 2025
Highlights from SABCS featuring new multimodal AI models developed by ECOG-ACRIN and Caris to advance recurrence risk assessment and personalized care in early-stage breast cancer
December 19, 2025
The trials explore potential treatment improvements for different cancer types: bladder, lung, lymphoma, myeloma, and stomach
December 19, 2025
Blood and breast cancer research highlights from the 67th American Society of Hematology Annual Meeting and Exposition, and the San Antonio Breast Cancer Symposium
November 21, 2025
The latest clinical trial findings in follicular lymphoma, prostate cancer, precision medicine, symptom science, and patient -reported outcomes
November 21, 2025
Timely information about research presented at medical meetings, recognition of research leaders, and more